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Prostaglandin (PC) Fja (30 PM) stimulated both monophosphorylation and diphosphorylation of myosin light chain (MLC) in a smooth muscle 
cell line (SM-3). The diphosphorylation was significantly decreased by treatment with the protein kinase C inhibitor staurosporine (30 nM, 30 
min) from 20.1% of total MLC to 4.5%. The protein kinase C down-regulation treatment of SM-3 cells with phorbol dibutyrate suppressed to 
8.7% the MLC diphospho~lation activity in the SM-3 cells. This down-regulation treatment had little effect on the monophosphorylation. We 
propose that the MLC diphosphorylation in PGF*,-stimulated SM-3 cells in culture may be regulated through mechanisms ensitive to protein 
kinase C. 
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1, INTRORUCTION 
Ikebe et al. reported that myosin light chain kinase 
(MLCK) catalyzed the rapid phosphorylation of 
isolated gizzard myosin light chain (MLC) at serine-19 
and that the second site (threonine-18) was phospho- 
rylated by an excess amount of MLCK [I ,2]. On the 
other hand, the Ca2+-activated phospholipid-dependent 
protein kinase C can also phosphorylate gizzard smooth 
muscle MLC at sites identified to be threonine-9, 
serine-1, and serine-2 [3,4], thereby decreasing the 
actin-activated Mg-ATPase activity and the contractile 
force [5,6]. Much of this evidence was obtained using in 
vitro systems or chemically permeable smooth muscle 
fibers. Thus, it is not clear whether multiple sites 
phosphorylation of MLC in intact contracting smooth 
muscle tissues or cells is the result of both MLCK and 
protein kinase C activities or MLCK activity alone. 
method to determine whether the PGFh-induced MLC 
diphosphorylation in contracting smooth muscle cells in 
culture is associated with the activity of MLCK or of 
protein kinase C. 
2. MATERIALS AND METHODS 
2.1. Smooth muscle cells SM-3 
Rabbit aortic smooth muscle cells (line SM-3) were cultured as 
described [8]. The contractile response to vasoactive substances was 
monitored with an Olympus phase-contrast microscope and determin- 
ed with a pianimeter, as described [PI. All the experiments were car- 
ried out with quiescent phase SM-3 cells: the postconfluent and 
growth-arrested cells were used as the seed culture, and the cells were 
plated and cultured at 3.5 x lo6 cells/100 mm dish containing 0.5% 
FCS-MEM for 2 days. The resulting cells were stimulated with PGFh 
in 20 mM Hepes-buffered MEM (pH 7.1) at 37°C. 
2.2. Down-re~~otion of protein kinase C 
We reported that the prostaglandin (PG)Fz,-induced 
contraction of rabbit aortic smooth muscle tissue [7] 
and cells (81 is associated with both MLC monophos- 
phorylation and diphosphorylation; when cultured 
SM-3 celis were stimulated with PGFti (30 FM), a 
relatively high level of the disphosphorylation occurred 
within 5 min. We have now used a biopharmacological 
The down-regulation of protein kinase C in SM-3 ceils was per- 
formed by adding 50 ng/ml phorbol dibutyrate (PDBu) followed by 
28 h incubation in a CO2 incubator, according to the method of 
Kariya et al. [lo]. After washing 3 times with warmed 20 mM Hepes- 
buffered MEM (pH 7.1), the cells were used for each experiment. Im- 
munoblot analysis of the protein kinase C isozymes was carried out 
with a minor modification of the method of Hidaka et al. [l 11 involv- 
ing DEAE cellulose column chromatography. 
2.3. Determination of MLC phosphorylation 
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Separation and determination of non-, mono-, and diphos- 
phorylated MLC were carried out by the method of Taylor and Stull 
[I21 with minor modification, as described ]7,8,13], a procedure 
which involves a glycerol-PAGE and a immunoblot analysis using 
anti-ML& antibody. After the PGFt, stimuIation, the cellular reac- 
tion was terminated with cold 10% trichloroacetic acid/l0 mM 
dithiothreitol12 mM EGTA solution. The resulting cell pellet 
(3.5 x lo6 cells) was washed twice with acetone/l0 mM dithiothreitol, 
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Fig. 1. Immunoblots of myosin light chain phosphorylation in PGFh-stimulated SM-3 cells. (A) Quiescent SM-3 cells were stimulated with OgM 
(l), 1 ,uM (2), 3 pM (3), 10~M (4), 30,~M (5) PGFh in 20 mM Hepes-buffered MEM (pH 7.1) at 37”C, and the stimulation was terminated by 
adding 10% TCA solution. Nonphosphorylated (MLC), monophosphorylated (MLC-P), and diphosphorylated (MLC-P2) forms of light chain 
were separated and analyzed by glycerol-PAGE/immunoblotting as described in section 2. (B) Immunoblot scanning of nonphosphorylated and 
phosphorylated myosin light chains. Densitometry of these blots and quantitation of absorbance peaks were carried out with a Densitron PAN-FV 
(Jookoo, Japan) equipped with a recording integrator. (1) Nonstimulated SM-3 fraction; (5) 30pM PGFh-stimulated SM-3 fraction. 
and then dried. The dried acetone powder was extracted with 35 pl of 
glycerol-PAGE sample buffer containing 8 M urea, then was passed 
through a 0.45pm membrane filter. The urea solubilized samples were 
subjected to glycerol-PAGE/immunoblot analysis. In our analysis, 
mono- and diphosphorylated MLCs were converted into the non- 
phosphorylated form by phosphomyosin-specific phosphatase, as 
described [7,13]. We confirmed these bands in [32P]ATP experiments: 
as “P-labeled SM-3 cells in culture were stimulated with PGFzu, 
labelled MLC-P was phosphorylated only on the serine residue, and 
Iabelled MLC-P2 was phosphorylated on the serine and threonine 
residues in a molar ratio of 1: 1. Thus, the mono- and diphosphoryla- 
tion fractions on immunoblotting paper may not involve any other 
protein fractions such as 28 kDa protein as pointed out by Colburn et 
al. [14]. 
3. RESULTS AND DISCUSSION 
Upon stimulation with PGFh of SM-3 cells, both 
monophosphorylated and diphosphorylated MLC frac- 
tions increased, in a dose- and time-dependent manner 
(Figs 1A and 2A) and a correlation with increases in cell 
contraction was evident (data not shown). With 30 PM 
PGFzcy stimulation, 42.9 I!I 0.4% (n = 4-5) of 
monophosphorylation and 20.1+ 6.2% (n = 4-5) of 
diphosphorylation were observed at 5 min (Fig. 2). The 
extent of MLC diphosphorylation appears to be 
distinctly high, as compared with the results reported by 
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Fig. 2. Time course of MLC phosphorylation in control (A) or Str-treated (B) SM-3 cells. (A) Quiescent SM-3 cells were stimulated with 30 pM 
PGFti, for the time shown, in 20 mM Hepes-buffered MEM (pH 7.1) at 37°C. (B) Quiescent SM-3 cells were exposed to 30 ,uM Str for 30 min 
at 37°C prior to PGFh stimulation. The figures represent the mean SE of 4-5 independent experiments. Phosphorylation levels are expressed as 
a % of the total extracted MLC. Symbols: (0) monophosphorylated MLC; (0) diphosphorylated MLC; (0) total phosphorylated MLC. 
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Fig. 3. Myosin light chain phosphorylation in PDBu-treated SM-3 cells and immunoblot analysis of protein kinase C. (A) Time course of MLC 
phosphorylation induced by PGFh in PDBu-treated SM-3 cells. Quiescent culture of SM-3 cells were treated with 50 ng/ml PDBu for 28 h. Then 
the cells were stimulated with 30 pM PCiFh for the time shown. (B) Immunoblot analysis of type III protein kinase C. The detergent extract of 
SM-3 cells (7 x lo6 cells) and of rabbit brain (140pg) were subjected to sodium dodecyl sulfate-PAGE and electrophoretic transfer to a nitrocellulose 
filter. Immunoblot analysis was made using the mono-clonal antibody (from Seikagaku Kogyo, Japan) against ype III isozyme of protein kinase 
C. (Lane 1) Rabbit brain extract; (lane 2) non-treated control cells extract; (lane 3) PDBu-treated (50 ng/ml, 28 h) cell extract. Symbols are the 
same as in Fig. 2. 
other investigators [12,14,15]. Like the case of aortic 
strip stimulation with PGFh [7], the diphosphorylation 
occurred even at concentrations over 3 ficM (Fig. 1). In 
contrast to evidence that multiple sites of smooth mus- 
cle MLC could be phosphorylated in vitro by both 
MLCK and protein kinase C with different rates and in- 
tensities of the enzyme activities [l-6,16], Colburn et al. 
proposed that the MLC in carbachol-stimulated intact 
tracheal smooth muscle may be diphosphorylated by 
MLCK at the serine and threonine residues but not by 
protein kinase C [14]. We made use of the protein 
kinase C inhibitor staurosporine (Str; prepared in Asahi 
Chem. Ind.) to determine which protein kinase is in- 
volved in the formation of diphosphorylation of MLC 
in SM-3 cells stimulated with PGF2,. Pretreatment of 
the SM-3 cells with Str (30 nM, 30 min) suppressed the 
formation of diphosphorylated MLC (Fig. 2B), which 
was significantly lower than that in the control cells 
(5.7 *2.3% vs 20.1+6.2%, at 5 min). Treatment with 
Str reduced the basal level of MLC monophosphoryla- 
tion (28.7 f 3.4% to 15.4* 3.3%, at 0 min), and also 50 
PM HA1077, a calcium antagonist [17], reduced the 
basal level to 5% or less (data not shown). However, it 
had little affect on the monophosphorylation activity 
(31.5+5.7% vs 42.9kO.4070, at 5 min; 26.6+5.4% vs 
37.7&2.5%, at 15 min). Treatment with high concen- 
tration of Str (50 nM, 30 min) reduced the 
monophosphorylation level of MLC (42.9 f 0.4% to 
16.8 + 1.6%). These results suggest hat there is MLC 
diphosphorylation pathway sensitive to Str treatment in 
SM-3 cells. We then examined whether or not phorbol 
ester-induced own-regulation of protein kinase C af- 
fects MLC diphosphorylation in the SM-3 cells. In the 
prolonged PDBu-treated (50 ng/ml, 28 h) SM-3 cells, 
PGFh induced MLC monophosphorylation to levels 
slightly lower than those seen in the control cells, but 
not significantly (Fig. 3A vs 2A). The PDBu-treatment 
lowered the basal level of monophosphorylation from 
28.7*3.4% to 21.9+ 1.7%. In contrast, the PGFh- 
induced diphosphorylation was suppressed in the 
PDBu-treated cells, but not completely: 20.1 f 6.2% to 
8.7 f 2.4%. Immunoblot analyses with specific mono- 
clonal antibodies against he type III isozyme were car- 
ried out to determine the amount of down-regulated 
protein kinase C. Fig. 3B shows that SM-3 cells con- 
tained the type III isozyme but not types I and II (data 
not shown), whereas the type III isozyme disappeared 
after a 28 h exposure to 50 ng/ml of PDBu. In this ex- 
periment, the PDBu-treatment did not completely sup- 
press the diphosphorylation activity despite the com- 
plete disappearance of type III protein kinase C. The 
residual diphosphorylation activity may be due to an 
activity of down-regulation insensitive protein kinase C 
since the protein kinase C activity in the PDBu-treated 
rabbit aortic smooth muscle cells remained at the level 
of 30-40% of the control cells [lo]. 
This report provides the first evidence suggesting that 
MLC diphosphorylation in intact smooth muscle cells 
may be regulated through a mechanism sensitive to pro- 
tein kinase C down-regulation and to the protein kinase 
C inhibitor Str, and different from mechanisms 
regulating monophosphorylation. 
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